spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Varian  


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 22 Apr 2026
Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA(R)
Diagnostics Oncology FDA
 HSMN NewsFeed - 21 Jul 2025
AKSM/Oncology Selects RayCare and RayStation For a New Cancer Center
Devices Oncology
 HSMN NewsFeed - 15 Jul 2025
Tract Bio Appoints Chris Galloway, M.D., as Chief Medical and Development Officer and Expands Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Dec 2024
Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Oct 2024
Accent Therapeutics Announces FDA Clearance of IND Application for ATX-559, a First-In-Class Oral DHX9 Inhibitor
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Sep 2024
Iridium Network becomes first center in the world to use RayCare and TrueBeam to treat a patient
Devices Oncology
 HSMN NewsFeed - 10 Apr 2024
TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 13 Feb 2024
ProfoundBio Raises $112 Million in Oversubscribed Series B Equity Financing to Advance its Clinical-Stage Antibody-Drug Conjugate (ADC) Pipeline
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 12 Feb 2024
AbbVie Completes Acquisition of ImmunoGen
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 9 Jan 2024
TORL BioTherapeutics Announces Appointment of Mark J. Alles as Chairman and Chief Executive Officer; Highlights Significant Progress of its Oncology Clinical Programs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Oct 2023
Antiva Biosciences Strengthens Leadership with Key New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 May 2023
RayCare is interoperable with Varian TrueBeam
Devices Oncology
 HSMN NewsFeed - 27 Dec 2022
Koya Medical Announces the Addition of Chief Medical Officer Dr. Thomas Maldonado to Their Executive Leadership Team
Devices Personnel
 HSMN NewsFeed - 18 Oct 2022
FDA Approves First IND of its Kind for Allogenic Exosomal Treatment of Female Reproductive Disorder - Primary Ovarian Insufficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Aug 2022
Calyptus Pharmaceuticals Announces FDA Approval of Cetrorelix Acetate for Injection, 0.25 mg/vial
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 19 Aug 2022
Verismo Therapeutics Announces Submission of IND Application to the FDA for SynKIR-110TM, a KIR-CAR T-cell Immunotherapy Candidate
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Aug 2022
U.S. FDA Accepts Astellas' New Drug Application for Fezolinetant
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Aug 2022
Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Mar 2022
Avenge Bio Appoints Claudio Dansky Ullmann, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Nov 2021
Kintara Announces Changes to Executive Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Oct 2021
Iridium Network invests in RayCare to become their primary oncology information system
Devices Oncology
 HSMN NewsFeed - 15 Oct 2021
SpinaFX Medical announces John Soloninka as Chief Operating Officer
Devices Neurosurgery Orthopaedic Personnel
 HSMN NewsFeed - 13 Oct 2021
Varian Receives FDA "Breakthrough Device Designation" For Embozene(R) Microspheres For Genicular Artery Embolization For Symptomatic Knee Osteoarthritis
Devices Interventional FDA
 HSMN NewsFeed - 22 Sep 2021
Kintara Reports Topline Results from Phase 2 Clinical Study of VAL-083 as Adjuvant Therapy for Newly-Diagnosed GBM Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Sep 2021
Sutro Biopharma Announces Expansion of Leadership Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Aug 2021
Sutro Biopharma Appoints Jane Chung as Chief Commercial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Aug 2021
BioInvent Announces Second Clinical Trial Collaboration and Supply Agreement to Evaluate BI-1808 in Combination with KEYTRUDA(R) (pembrolizumab) in Patients with Advanced Solid Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Jul 2021
Elevar Therapeutics Announces New Appointments to Strengthen its Executive and Senior Leadership Teams
Biopharmaceutical Personnel
 HSMN NewsFeed - 8 Jul 2021
Theolytics expands Series A financing and welcomes M Ventures as a new investor
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 May 2021
Varian Receives FDA "Breakthrough Device Designation" for its Cardiac Radioablation (CRA) System for Treatment of Refractory Ventricular Tachycardia (VT)
Devices Cardiology FDA
 HSMN NewsFeed - 23 Apr 2021
GLOBAL Sarcoma Therapy Now Approved for Australian Patients
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Mar 2021
Sutro Biopharma Strengthens Leadership Through Management Promotions and Expansion of Clinical Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Mar 2021
Varian Announces CEO Succession Plan
Devices Oncology Personnel Mergers & Acquisitions
 HSMN NewsFeed - 23 Feb 2021
Elicio Therapeutics Announces FDA Clearance of IND application for ELI-002-- A Therapeutic Vaccine Targeting mutated KRAS Cancers
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Jan 2021
Myeloid Therapeutics Launches with Over $50 Million in Financing and Two Clinical Trials
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 29 Dec 2020
AIVITA Biomedical Closes $25 Million Financing Round
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 28 Dec 2020
Elevar Therapeutics Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea(R) (Paclitaxel Micellar) in Europe
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 21 Dec 2020
Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Nov 2020
Sutro Biopharma Announces the Appointment of Diana Landa as Vice President of Regulatory Affairs and Annie Chang as Head of Investor Relations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Oct 2020
Varian Receives Investigational Device Exemption (IDE) and Prepares for First Ever Clinical Trial of FLASH Therapy
Devices Oncology FDA
 HSMN NewsFeed - 14 Sep 2020
Varian Announces Appointment of Chris Toth as President and Chief Operating Officer
Devices Oncology Personnel
 HSMN NewsFeed - 20 Aug 2020
Kintara Therapeutics (Formerly DelMar Pharmaceuticals) Announces Completion of Merger with Adgero Biopharmaceuticals and Closing of $19.6 Million Private Placement Priced At-The-Market
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 17 Aug 2020
DelMar Announces Approval of Merger by Stockholders
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 2 Aug 2020
Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 25 Jun 2020
Long-Term Results from SABR-COMET Further Demonstrate Effectiveness of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Metastatic Cancers
Devices Oncology
 HSMN NewsFeed - 8 Jun 2020
HistoSonics Announces $40 Million Financing
Devices Venture Capital
 HSMN NewsFeed - 28 May 2020
RaySearch Enters Into Interoperability Agreement With Varian
Devices Oncology
 HSMN NewsFeed - 26 May 2020
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 May 2020
Varian Launches New Noona(R) Capabilities to Meet Growing Demand for Remote Cancer Patient Monitoring in Response to COVID-19's Impact on Healthcare
Devices Oncology Product Launch
 HSMN NewsFeed - 21 May 2020
Sutro Biopharma Expands Senior Management with the Additions of Vice President of Clinical Development and Vice President of Finance and Controller
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Mar 2020
Elevar Therapeutics Acquires Global Rights to European Approved Apealea(R) from Oasmia Pharmaceutical
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 17 Mar 2020
Alabama's Only Proton Therapy Center Treats First Patient with Varian ProBeam
Devices Oncology
 HSMN NewsFeed - 2 Mar 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 13 Feb 2020
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
Devices Personnel
 HSMN NewsFeed - 5 Feb 2020
Sutro Biopharma Expands Senior Management Team with the Appointments of Vice President of Immunobiology and Vice President of Business Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Jan 2020
Varian Appoints Prof. Dr. Ricky Sharma VP of Clinical Affairs
Devices Oncology Personnel
 HSMN NewsFeed - 13 Jan 2020
Bardy Diagnostics(TM) Names Ed Vertatschitsch as Chief Operating Officer and Announces Additions to the Leadership Team
Devices Monitoring Cardiology Personnel
 HSMN NewsFeed - 13 Jan 2020
CNS Pharmaceuticals Licenses DNA-Binding Agent from MD Anderson, Doubling its Drug Pipeline
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 19 Dec 2019
MaxCyte Appoints New Executive Vice President, Business Development for CARMA(TM) Cellular Therapies and Provides Clinical Trial Update
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Nov 2019
CNS Pharmaceuticals Entered $2.0 Million Sublicense Agreement with WPD Pharmaceuticals
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 19 Nov 2019
CNS Pharmaceuticals Acquired Worldwide Rights for Brain Cancer Drug from Houston Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Nov 2019
Varian Selected by Michigan Oncology Quality Consortium to Support Transition to Value-Based Care
Devices Oncology
 HSMN NewsFeed - 28 Oct 2019
Anixa Biosciences Names Novartis Executive Dr. Emanuele Ostuni to Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Oct 2019
On Target Laboratories Appoints Vice President of Regulatory and Quality
Diagnostics Oncology Personnel
 HSMN NewsFeed - 15 Oct 2019
Cyteir Therapeutics Secures Additional $40.2 Million in Its Series B Financing and Doses First Patient in Phase 1/2 Study of First-in-Class RAD51 Inhibitor
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 16 Sep 2019
Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System
Devices Oncology Product Launch
 HSMN NewsFeed - 4 Sep 2019
NW Bio Expands Senior Management Team With Dr. Kevin Duffy As Vice President, Medical Affairs & External Collaborations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Sep 2019
Laboratory for Advanced Medicine Receives FDA Breakthrough Device Designation for Liquid Biopsy Liver Cancer Detection Test
Diagnostics Oncology FDA
 HSMN NewsFeed - 19 Aug 2019
Boston Scientific Closes Acquisition of BTG plc.
Devices Interventional Oncology Mergers & Acquisitions
 HSMN NewsFeed - 12 Aug 2019
On Target Laboratories Announces Leadership Transition and Appoints Christopher Barys as Chief Executive Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 5 Aug 2019
AbbVie Submits New Drug Application to US FDA for Investigational Elagolix for Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Women
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jul 2019
Three Radiotherapy Centers in Serbia Standardize on Varian Solution for Cancer Treatment Planning
Devices Oncology
 HSMN NewsFeed - 9 Jul 2019
BioMarin Appoints Pharmaceutical Veteran and Former J & J Executive, Liz McKee Anderson, to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jul 2019
Varian to Expand Interventional Oncology Portfolio with Purchase of Embolic Bead Asset
Devices Interventional Acquisitions
 HSMN NewsFeed - 25 Jun 2019
Nevro Announces Executive Appointments
Devices Personnel
 HSMN NewsFeed - 24 Jun 2019
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 21 May 2019
DelMar Pharmaceuticals Announces Expansion of Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 May 2019
Cyclotron for Varian ProBeam Compact Proton Therapy System Installed at New Treatment Center in Singapore
Devices Oncology
 HSMN NewsFeed - 9 May 2019
Varian Acquires CyberHeart
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 9 May 2019
Varian and Shandong Cancer Hospital Form Proton Therapy Clinical Application and Research Partnership in China
Devices Oncology
 HSMN NewsFeed - 3 May 2019
New Study From Invitae Highlights the Importance of Multigene Genetic Testing for Uterine Cancer Patients
Diagnostics Oncology
 HSMN NewsFeed - 30 Apr 2019
South Africa Hospital Delivers HDR Brachytherapy Cancer Treatments with Varian Bravos Afterloader System
Devices Oncology
 HSMN NewsFeed - 16 Apr 2019
Aprea Therapeutics Receives FDA Fast Track Designation and Orphan Drug Designation for APR-246 for the Treatment of Myelodysplastic Syndromes (MDS)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Apr 2019
HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing
Devices Venture Capital
 HSMN NewsFeed - 4 Apr 2019
DelMar Pharmaceuticals Welcomes Dr. John de Groot, Chairman, ad interim of the Department of Neuro-Oncology at MD Anderson Cancer Center, as founding member of the Company's Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Apr 2019
Varian Discloses First Preclinical Results of Potential Major Breakthrough in Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 11 Mar 2019
Varian and Tata Trusts Sign Framework Agreement for Advanced Cancer Care Solutions to Address Growing Need in India
Devices Oncology
 HSMN NewsFeed - 27 Feb 2019
Aprea Therapeutics Adds New Investor to Series C Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 26 Feb 2019
NW Bio Hires David Innes As Vice President, Investor Relations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Feb 2019
Marker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Jan 2019
Varian Installs Gantry for ProBeam Compact Proton Therapy System at New Treatment Center in Singapore
Devices Oncology
 HSMN NewsFeed - 17 Jan 2019
First Cancer Patients in Taiwan Treated with Varian HyperArc High-Definition Radiotherapy
Devices Oncology
 HSMN NewsFeed - 24 Dec 2018
Varian U.S. Tariff Exclusion Request Granted for Halcyon Radiotherapy System for Cancer Treatments
Devices Oncology
 HSMN NewsFeed - 19 Nov 2018
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Oct 2018
Duchesnay Inc. Announces Submission of Supplemental New Drug Application (sNDA) for Osphena(R) (ospemifene) to U.S. FDA Seeking Approval for the Treatment of Vaginal Dryness, a Symptom of Vulvar and Vaginal Atrophy (VVA) Due to Menopause
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Oct 2018
FDA Approves Medicines360's sNDA for LILETTA(R) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 12 Oct 2018
Varian Expands Cancer Care Portfolio with Noona Healthcare Acquisition
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 28 Sep 2018
ITUS Corporation Changing Company Name to Anixa Biosciences and Stock Ticker Symbol to ANIX
Biopharmaceuticals Diagnostics Oncology
 HSMN NewsFeed - 24 Sep 2018
Cumberland Pharmaceuticals Announces Senior Music Industry Executive Joins Its Board Of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Sep 2018
Quest Diagnostics Acquires ReproSource, Extending Into Advanced Fertility Diagnostics
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 12 Sep 2018
Dr. Jeff Balser Named to Varian Board of Directors
Devices Oncology Personnel
 HSMN NewsFeed - 7 Sep 2018
Varian Signs Partnership Agreement with Mediheal to Support Cancer Care in Kenya
Devices Oncology
 HSMN NewsFeed - 4 Sep 2018
Varian Installs Cyclotron for ProBeam Compact Proton Therapy System at Treatment Center in Florida
Devices Oncology
 HSMN NewsFeed - 22 Aug 2018
Sierra Oncology Obtains Debt Facility from Silicon Valley Bank to Acquire and Advance Momelotinib
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 22 Aug 2018
Sierra Oncology Acquires Momelotinib, an Investigational Janus Kinase (JAK) 1/2 and Activin Receptor Type 1 (ACVR1) Inhibitor for Myelofibrosis, from Gilead Sciences
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 21 Aug 2018
Varian CEO Dow Wilson Joins USISPF Board of Directors
Devices Oncology Personnel
 HSMN NewsFeed - 13 Aug 2018
Cumberland Pharmaceuticals Appoints New Senior Executive
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Aug 2018
Varian Announces Acquisition of humediQ Global GmbH
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 27 Jul 2018
PharmaMar Reaches an Agreement With Impilo Pharma, a Part of Immedica Group, for the Promotion and Distribution of Yondelis(R) in the Nordic Countries and Eastern Europe
Biopharmaceuticals Oncology Distribution
 HSMN NewsFeed - 24 Jul 2018
AbbVie Receives U.S. FDA Approval of ORILISSA(TM) (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 25 Jun 2018
DelMar Pharmaceuticals Appoints World-Renowned Molecular Biologist Dr. Napoleone Ferrara to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2018
AIVITA Biomedical Announces U.S. Food and Drug Administration Clearance of IND for Phase II Glioblastoma Multiforme Trial
Regenerative Medicine Oncology FDA
 HSMN NewsFeed - 14 Jun 2018
Varian Provides Update on Proposed Sirtex Acquisition
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 7 Jun 2018
Egalet Appoints Industry Veteran John Varian to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2018
Varian Notifies Sirtex It Will Not Submit a Counterproposal to Competing Bid
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 16 May 2018
TapImmune Creates Scientific Advisory Board to Support Clinical Development of Multi-Antigen Cell Therapy Platform
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 May 2018
Varian Acquires Taiwan Distributor
Devices Oncology Distribution Mergers & Acquisitions
 HSMN NewsFeed - 4 May 2018
Varian Notes Receipt of Competing Bid by Sirtex
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 25 Apr 2018
MaxCyte Appoints Dr. Claudio Dansky Ullmann as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Apr 2018
SELLAS Life Sciences Announces Appointment of Gene Mack as Chief Financial Officer & Treasurer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Apr 2018
Varian Expands Capabilities of Halcyon Treatment System with New Imaging Technologies
Devices Oncology
 HSMN NewsFeed - 9 Apr 2018
Cumberland Pharmaceuticals Expands into Oncology Support
Biopharmaceuticals Oncology Licensing Distribution
 HSMN NewsFeed - 23 Mar 2018
Caris Life Sciences Announces Published Results Showing that its ADAPT Biotargeting System Effectively Stratified Breast Cancer Patients Based on Their Benefit from Trastuzumab Treatment (Herceptin)
Biopharmaceuticals Diagnostics Oncology
 HSMN NewsFeed - 13 Mar 2018
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
Biopharmaceuticals Personalized Medicine Licensing
 HSMN NewsFeed - 6 Mar 2018
FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes
Diagnostics Oncology FDA
 HSMN NewsFeed - 23 Feb 2018
Kazia Receives FDA Orphan Designation for GDC-0084
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Feb 2018
Varian Acquires Evinance Innovation, Inc.
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 6 Feb 2018
Varian Halcyon Treatment System Receives AERB Certificate for Import & Supply in India
Devices Oncology Regulatory
 HSMN NewsFeed - 5 Feb 2018
Varian Acquires Mobius Medical Systems
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 30 Jan 2018
Varian Signs Agreement to Acquire Sirtex
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 16 Jan 2018
MabVax Therapeutics Holdings, Inc. Provides Business Strategy Update
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Jan 2018
Morphotek Announces FDA Acceptance Of Investigational New Drug Application For Next-Generation Farletuzumab Antibody-Drug Conjugate MORAb-202
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Jan 2018
Varian Halcyon Treatment System Receives Taiwan FDA Approval
Devices Oncology Regulatory
 HSMN NewsFeed - 14 Dec 2017
Silk Therapeutics Appoints Dr. Rebecca Lacouture to Company President
Devices Personnel
 HSMN NewsFeed - 6 Dec 2017
Varian Halcyon Treatment System Receives ANVISA Registration in Brazil
Devices Oncology Regulatory
 HSMN NewsFeed - 27 Nov 2017
Laura Shawver, Ph.D., Appointed CEO of Synthorx
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2017
Arterys Completes Series B to Accelerate Product Commercialization
Devices Radiology Venture Capital
 HSMN NewsFeed - 13 Nov 2017
EMD Serono Receives FDA Approval for New GONAL-f(R) RFF Redi-ject(R) Pen
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 10 Nov 2017
Amgen And Allergan Receive Positive CHMP Opinion For ABP 215 (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 6 Nov 2017
Treatments Commence at Two Algerian Hospitals Equipped with Modern Varian Radiotherapy Systems
Devices Oncology
 HSMN NewsFeed - 3 Nov 2017
Varian Selected in Multi-Year Project to Replace Radiotherapy Treatment Equipment at Copenhagen's Rigshospitalet and Herlev Hospital
Devices Oncology
 HSMN NewsFeed - 3 Nov 2017
ViewRay's MRIdian Linac Selected as MR-Guided Radiotherapy System in Danish Tender
Devices Oncology
 HSMN NewsFeed - 30 Oct 2017
Varian Names New Chief People Officer, SVP HR
Devices Oncology Personnel
 HSMN NewsFeed - 27 Oct 2017
AbbVie Receives U.S. FDA Priority Review for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Oct 2017
First Patients in US Treated with Varian HyperArc High Definition Radiotherapy
Devices Oncology
 HSMN NewsFeed - 19 Oct 2017
European Court of Appeal Rejects Varian's Attempt to Reverse Customer Purchase of Accuray TomoTherapy(R) System
Devices Oncology Litigation
 HSMN NewsFeed - 17 Oct 2017
UZ Leuven Treats First Patient in Europe on Varian Halcyon Cancer Treatment System
Devices Oncology
 HSMN NewsFeed - 11 Oct 2017
SutroVax Appoints Veteran Vaccine Experts to Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Sep 2017
Cumberland Pharmaceuticals Launches Promotion of Totect(R) in The U.S. for Emergency Oncology Intervention
Biopharmaceuticals Oncology Product Launch
 HSMN NewsFeed - 25 Sep 2017
TapImmune Appoints Peter Hoang as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Sep 2017
Varian Announces Penn Medicine Treats World's First Patient on Halcyon System
Devices Oncology
 HSMN NewsFeed - 19 Sep 2017
Varian to Showcase Latest Technologies and Software for Advanced Cancer Care at ASTRO 2017
Devices Oncology
 HSMN NewsFeed - 6 Sep 2017
AbbVie Submits New Drug Application to U.S. FDA for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Sep 2017
Morphotek(R), Inc. Announces an Agreement with Fujirebio Diagnostics, Inc. to Commercialize the CA125 II Assay as a Companion Diagnostic for Farletuzumab(R)
Biopharmaceuticals Diagnostics Oncology Licensing
 HSMN NewsFeed - 9 Aug 2017
Varian Medical Systems Signs Brachytherapy Applicator Distribution Agreement with Bionix Radiation Therapy
Devices Oncology Distribution
 HSMN NewsFeed - 8 Aug 2017
First Patient Treated with Varian HyperArc High Definition Radiotherapy
Devices Oncology
 HSMN NewsFeed - 7 Aug 2017
FDA Approves Medicines360's sNDA for LILETTA(R) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Four Years
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 11 Jul 2017
DelMar Pharmaceuticals Appoints Saiid Zarrabian to the Board of Directors and Names Dr. Erich Mohr as Chairman
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Jul 2017
Gail S. Page Joins Chembio Diagnostics Board of Directors
Diagnostics HIV/AIDS Personnel
 HSMN NewsFeed - 22 Jun 2017
DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Jun 2017
Avant Diagnostics Appoints Philippe Goix, PhD, MBA as President & CEO to Commercialize Proprietary Theralink(R) Tumor Biomarker Platform
Diagnostics Oncology Personnel
 HSMN NewsFeed - 24 May 2017
Varian Selected to Provide First Proton Therapy System in Thailand
Devices Oncology
 HSMN NewsFeed - 10 May 2017
Varian ProBeam Proton Therapy System Receives Shonin Approval
Devices Oncology Regulatory
 HSMN NewsFeed - 8 May 2017
New Varian Cancer Treatment Platform Draws Large Crowds at ESTRO 36 Tradeshow
Devices Oncology
 HSMN NewsFeed - 10 Apr 2017
First-Ever Live Laparoscopic Surgery Using Image-Guided Robotically Assisted System
Devices Surgery
 HSMN NewsFeed - 5 Apr 2017
Varian Medical Systems Names New CFO
Devices Oncology Personnel
 HSMN NewsFeed - 4 Apr 2017
Relay Therapeutics Appoints Pharmaceutical Leader Sanjiv K. Patel, M.D. to President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2017
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 27 Mar 2017
Bovie Medical Receives 510K Clearance for Its Cool-Coag(TM) Generator and Open Handpiece
Devices Surgery FDA
 HSMN NewsFeed - 1 Mar 2017
José Baselga and Jean-Luc Butel Appointed to Board of Directors of Varian Medical Systems
Devices Oncology Personnel
 HSMN NewsFeed - 17 Feb 2017
LYNPARZA(TM) (olaparib) Meets Primary Endpoint in Phase III Trial in BRCA-Mutated Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Feb 2017
Syndax Appoints Richard P. Shea as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Jan 2017
Verastem Announces Executive Leadership Appointments and Changes
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Jan 2017
Varian Medical Systems Announces Distribution Ratio And Record Date For Separation Of Imaging Components Business
Devices Radiology Oncology
 HSMN NewsFeed - 9 Jan 2017
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 20 Dec 2016
Foundation Medicine Receives FDA Approval of FoundationFocus(TM) CDxBRCA as a Companion Diagnostic for Rubraca(TM) (rucaparib) for the Treatment of Women with Ovarian Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 15 Dec 2016
Brainlab ExacTrac Integrates Varian’s PerfectPitch to Enable Highly Accurate Radiosurgery Treatments With Advanced 6D Correctional Accuracy
Devices Oncology Neurosurgery Product Launch
 HSMN NewsFeed - 7 Dec 2016
Panther Biotechnology Receives Positive Feedback from the FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Nov 2016
Myriad Will Seek Japanese Regulatory Approval for BRACAnalysis CDx(R)
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 2 Nov 2016
Verastem Licenses Duvelisib from Infinity Pharmaceuticals
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 31 Oct 2016
USITC Publishes Initial Determination in Litigation Dispute
Devices Oncology Litigation
 HSMN NewsFeed - 31 Oct 2016
Novogen Acquires Privately-held Neuro-oncology Company to Support Development of GDC-0084 in Glioblastoma
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 28 Oct 2016
Astellas to Acquire Ganymed Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Oct 2016
Rosetta Genomics Appoints Mark R. Willig as Chief Commercial Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 19 Oct 2016
SELLAS(TM) Life Sciences Appoints Former Barclays Biotechnology Research Analyst as Chief Business and Strategy Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Oct 2016
RXi Pharmaceuticals Enters into Exclusive Option Agreement to Acquire MirImmune Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 3 Oct 2016
Launch of Carrick Therapeutics Signals New Approach to Cancer Therapies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 26 Sep 2016
Varian Exhibiting New HyperArc Technology for High Definition Radiotherapy and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 15 Sep 2016
Varian Medical Systems Receives FDA 510(k) Clearance for Nexus DR Digital X-Ray Imaging System
Devices Radiology Oncology FDA
 HSMN NewsFeed - 6 Sep 2016
OncoSec Appoints Sharron Gargosky, PhD, to Chief Clinical and Regulatory Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Aug 2016
Judy Bruner Appointed to Board of Directors of Varian Medical Systems; Venkatraman Thyagarajan Retires from Varian Board
Devices Oncology Personnel
 HSMN NewsFeed - 1 Aug 2016
Varian Medical Systems Selected to Supply First Modern Radiotherapy Systems in Ethiopia
Devices Oncology
 HSMN NewsFeed - 10 Jun 2016
AiVita Biomedical Raises $2m in Series A Financing for Commercial and Clinical-Stage Program Development
Regenerative Medicine Venture Capital Personnel
 HSMN NewsFeed - 9 Jun 2016
Varian and Russian Proton Therapy Center Achieve Milestone with Cyclotron Installation
Devices Oncology
 HSMN NewsFeed - 2 Jun 2016
FDA Grants Orphan Drug Designation to Debiopharm International SA's IAP Inhibitor Debio 1143 in the Treatment of Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Apr 2016
Varian Gives European Clinicians First Glimpse of Next Big Advance in Radiotherapy at ESTRO 35
Devices Oncology
 HSMN NewsFeed - 27 Apr 2016
Proton Therapy Center Initiates 3D Image Guided Proton Therapy to Enhance Precision of Cancer Care
Devices Oncology
 HSMN NewsFeed - 21 Apr 2016
FDA Grants Orphan Drug Designation For VAL-083 In Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Apr 2016
Synta and Madrigal Announce Merger Agreement to Create Leading Cardiovascular-Metabolic Diseases and NASH Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Apr 2016
Immunovaccine Names Frederic Ors Chief Executive Officer; Andy Sheldon, Medicago CEO, to Join Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2016
Janssen Enters Worldwide Collaboration and License Agreement with TESARO, Inc., for Niraparib in Prostate Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 22 Mar 2016
Varian Launches New Smaller Calypso Beacon Transponder To Guide Radiation Therapy In Soft Tissue Tumors
Devices Oncology FDA Regulatory Product Launch
 HSMN NewsFeed - 18 Mar 2016
The Myriad myRisk(R) Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations in Patients with Endometrial Cancer
Diagnostics Oncology Personalized Medicine
 HSMN NewsFeed - 9 Mar 2016
Karolinska Development's Portfolio Company Aprea Raises SEK 437 Million
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 7 Mar 2016
Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 3 Mar 2016
Allergan Launches Bold Access To LILETTA(R) (levonorgestrel-releasing intrauterine system)
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 3 Feb 2016
TapImmune Granted Fast Track Designation by U.S. Food & Drug Administration for its Lead Vaccine TPIV 200 in the Treatment of Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Jan 2016
Varian Medical Systems Appoints Dr. Patrick Kupelian VP of Clinical Affairs
Devices Oncology Personnel
 HSMN NewsFeed - 26 Jan 2016
Abcodia Announces Expanded U.S. Availability of the ROCA(R) Test for Early Ovarian Cancer Detection
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 20 Jan 2016
Allan L. Shaw Joins Syndax Pharmaceuticals As Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Jan 2016
Oncimmune Appoints Greg Stanley as President of Commercial Operations
Diagnostics Oncology Personnel
 HSMN NewsFeed - 8 Jan 2016
MDNA Life Sciences Appoints New Management Team Members to Lead Development and Commercialization of Mitochondrial Diagnostic Pipeline
Diagnostics Oncology Personnel
 HSMN NewsFeed - 8 Jan 2016
Dr. Rolf Muller Appointed as New CEO of BioFluidica, Inc.
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Jan 2016
OvaScience Names Harald F. Stock Chief Executive Officer-Elect
Devices Personnel
 HSMN NewsFeed - 7 Dec 2015
Nemucore Medical Innovations Completes Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 19 Nov 2015
Oncimmune Appoints Dr James Jett, World Recognised Lung Cancer Specialist, as Chief Medical Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 18 Nov 2015
Merck KGaA, Darmstadt, Germany, and Pfizer Receive FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Oct 2015
AVAX Technologies, Inc. Announces the Appointment of Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Oct 2015
Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone
Biopharmaceuticals
 HSMN NewsFeed - 14 Oct 2015
Eclipse(TM) Treatment Planning Software from Varian Now Offers Robust Optimization and Proton Therapy Dose Calculation Tools
Devices Oncology FDA Product Launch
 HSMN NewsFeed - 12 Oct 2015
Varian Medical Systems Receives CE Mark for its Latest ProBeam(R) Proton Therapy System
Devices Oncology Regulatory
 HSMN NewsFeed - 29 Sep 2015
Elekta States That Varian Claims Lack Merit
Devices Oncology Litigation
 HSMN NewsFeed - 25 Sep 2015
Merck and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Sep 2015
Cerulean Appoints David R. Walt, Ph.D. to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Sep 2015
ImmunoCellular Therapeutics Appoints Mark A. Schlossberg and Gregg A. Lapointe to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Jul 2015
Kailos Genetics Hires Cheri Walker as Chief Financial Officer
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 27 Jul 2015
Varian Signs Contracts to Equip Two National Proton Therapy Centers in England
Devices Oncology
 HSMN NewsFeed - 20 Jul 2015
BioMarin Provides Program Update for Talazoparib in Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 May 2015
RaySearch Laboratories: First Proton Treatments with RayStation and MEVION S250
Devices Oncology Product Launch
 HSMN NewsFeed - 20 Apr 2015
Oasmia's Lead Cancer Product Paclical(R) Receives Market Approval in the Russian Federation
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 13 Apr 2015
Actavis and Medicines360 Announce U.S. Availability of LILETTA(TM) (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 25 Mar 2015
VBL Therapeutics Reports Interim Topline Results From Phase 2 Clinical Trial of VB-111 in Recurrent Glioblastoma (rGBM)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Mar 2015
OXiGENE, Inc. Announces $10 Million At-the-Market Registered Direct Offering
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 11 Mar 2015
Varian Medical Systems Selected to Equip Two National Proton Therapy Centers in England
Devices Oncology
 HSMN NewsFeed - 4 Mar 2015
Bristol-Myers Squibb Signs Exclusive Agreement with Bavarian Nordic for PROSTVAC(R), a Prostate-Specific Antigen-Targeting Cancer Immunotherapy
Biopharmaceuticals Licensing Oncology
 HSMN NewsFeed - 27 Feb 2015
Varian Medical Systems to Make Radiotherapy Available for More Cancer Patients in Africa
Devices Oncology
 HSMN NewsFeed - 23 Feb 2015
Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Feb 2015
U.S. FDA Grants Priority Review for YONDELIS(R) (trabectedin) for the Treatment of Patients with Advanced Soft Tissue Sarcoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Feb 2015
CTI BioPharma Announces Independent DMC Recommendation to Continue GOG-0212 Phase 3 Study of OPAXIO(TM) as Maintenance Therapy in Ovarian Cancer, an NRG Oncology/GOG Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Jan 2015
Cerulean Appoints Vice President, Clinical Operations
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 27 Jan 2015
ONCOLIX, INC. Announces Capital Raise of $4.2 Million
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 8 Jan 2015
Myriad Obtains CE Mark for Tumor BRACAnalysis CDx(TM) and Launches Test in Europe as Companion Diagnostic for PARP Inhibitors
Diagnostics Oncology Regulatory
 HSMN NewsFeed - 5 Jan 2015
Aduro Biotech Closes $51.4 Million Series D Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Dec 2014
Oncolytics Biotech(R) Inc. Announces Filing for Orphan Drug Designation with the U.S. FDA for Pancreatic and Ovarian Cancers
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Oct 2014
RaySearch Laboratories: Raysearch Receives FDA Clearance for RayStation 4.5 Featuring Ultrafast and Robust Optimization
Devices Oncology FDA
 HSMN NewsFeed - 24 Oct 2014
Myriad Establishes Tumor BRACAnalysis CDx(TM) Laboratory in Europe
Diagnostics Oncology
 HSMN NewsFeed - 11 Sep 2014
Cyclacel Pharmaceuticals Appoints Samuel L. Barker, Ph.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Sep 2014
Johnson & Johnson Responds to Ebola Crisis With Commitment to Accelerate Vaccine Program in Collaboration With the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid
Biopharmaceuticals
 HSMN NewsFeed - 14 Aug 2014
Vermillion Announces Additions to Commercial Management Team
Diagnostics Personnel
 HSMN NewsFeed - 30 Jul 2014
Study Shows that RapidArc(R) Radiosurgery Substantially More Efficient and Comparable in Quality to Gamma Knife(R) in the Treatment of Multiple Brain Metastases
Devices Oncology
 HSMN NewsFeed - 28 Jul 2014
Celsion Announces Updated Overall Survival Data from HEAT Study of ThermoDox(R) in Primary Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Jul 2014
Varian Medical Systems Receives FDA 510(k) Clearance for Calypso(R) Soft Tissue Beacon(R) Transponder
Devices Oncology FDA
 HSMN NewsFeed - 20 Jun 2014
ERBA Diagnostics, Inc. Appoints William Creech as Vice President Sales and Marketing
Diagnostics Personnel
 HSMN NewsFeed - 13 Jun 2014
Varian Medical Systems to Equip Prime Healthcare Services Hospitals with Varian Technology for Image-Guided Radiotherapy and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 13 Jun 2014
EntreMed Stockholders Approve Name Change To CASI Pharmaceuticals
Biopharmaceuticals
 HSMN NewsFeed - 2 Jun 2014
Doctors at Community Cancer Center Treat Inoperable Lung Cancer Using TrueBeam System for Image-Guided Radiotherapy and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 2 Jun 2014
Myriad Presents Clinical Data on Myriad myRisk(TM) Hereditary Cancer Test at ASCO
Diagnostics Oncology
 HSMN NewsFeed - 29 May 2014
Aduro Announces License Agreement with Johnson & Johnson Innovation for Novel Immunotherapies for Prostate Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 27 May 2014
Varian Medical Systems To Equip New Proton Treatment Center at the National Taiwan University in Taipei
Devices Oncology
 HSMN NewsFeed - 27 May 2014
Bristol-Myers Squibb and Incyte Enter Clinical Collaboration Agreement to Evaluate Combination Regimen of Two Novel Immunotherapies
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 May 2014
RaySearch Laboratories: RaySearch receives 510(k) clearance for Pencil Beam Scanning with protons
Devices Oncology FDA
 HSMN NewsFeed - 19 May 2014
Pamela Youde Nethersole Eastern Hospital First in Asia to Treat Cancer using TrueBeam 2.0 System for Image-Guided Radiotherapy and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 9 May 2014
Prima BioMed's CVac(TM) Granted Fast Track Designation by FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 May 2014
Merck and Endocyte Announce Independent DSMB Recommends Vintafolide PROCEED Phase 3 Trial Be Stopped for Futility Following Interim Analysis
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 May 2014
Myriad to Launch EndoPredict(R) in Canada
Diagnostics Oncology Personalized Medicine
 HSMN NewsFeed - 28 Apr 2014
Vermillion Launches ASPiRA LABS
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 25 Apr 2014
Chugai Pharma USA Announces Appointment of Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Apr 2014
Leading Cancer Center in Italy Introduces Wider Range of Non-Surgical Cancer Treatments Using Varian's Edge(TM) Radiosurgery System
Devices Oncology
 HSMN NewsFeed - 27 Mar 2014
Merck Announces Initiation of Phase III Fertility Study with Pergoveris in Poor Ovarian Response Patients
Biopharmaceuticals
 HSMN NewsFeed - 26 Mar 2014
Zogenix Appoints James Breitmeyer to Its Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 21 Mar 2014
 Merck and Endocyte Announce European CHMP Positive Opinions for VYNFINIT(R) (vintafolide) and Companion Imaging Agents FOLCEPRI(R) (etarfolatide) and NEOCEPRI(R) (Intravenous (IV) folic acid) in Patients with Platinum-Resistant Ovarian Cancer
Biopharmaceuticals Oncology Radiology Regulatory
 HSMN NewsFeed - 19 Mar 2014
RaySearch Secures Distribution of Raystation(R) in Australia and New Zealand
Devices Oncology Distribution
 HSMN NewsFeed - 17 Mar 2014
Veracyte, Inc. Appoints Julie A. Brooks as Executive Vice President, General Counsel and Secretary; and Andy Thorson as Executive Vice President, Corporate Strategy and Business Development
Diagnostics Personnel
 HSMN NewsFeed - 12 Mar 2014
Rosetta Genomics Provides Product Pipeline Update
Diagnostics
 HSMN NewsFeed - 6 Mar 2014
Varian Medical Systems to Exhibit Wireless Flat Panel Detectors, X-Ray Tubes for Digital Radiography and Image Processing Software at the European Congress of Radiology
Devices Radiology Oncology
 HSMN NewsFeed - 5 Mar 2014
Leading Cancer Center in Portugal Becomes First in World to Offer Edge(TM) Radiosurgery
Devices Oncology
 HSMN NewsFeed - 28 Feb 2014
InterMune(R) Announces Support for First Ever European Patient Charter on Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals
 HSMN NewsFeed - 31 Jan 2014
RaySearch Laboratories: First RayStation(R) Order in the United Kingdom
Devices Oncology
 HSMN NewsFeed - 15 Jan 2014
Varian Medical Systems Receives FDA 510(k) Clearance for its ProBeam(TM) Proton Therapy System
Devices Oncology FDA
 HSMN NewsFeed - 13 Jan 2014
Insys Announces Details of Product Development Pipeline
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 9 Jan 2014
Lion Biotechnologies Appoints James Bender, Ph.D., as Vice President, Product Development and Manufacturing
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 20 Dec 2013
RaySearch Laboratories: Columbia University Hospital – New York City extends clinical partnership with RaySearch
Devices Radiology Oncology
 HSMN NewsFeed - 16 Dec 2013
EMD Serono's Redesigned Fertility Pen Available for Distribution in US
Biopharmaceuticals Drug Delivery Product Launch
 HSMN NewsFeed - 16 Dec 2013
Varian Imaging Components President Robert Kluge Announces Plans to Retire; Varian CEO Dow Wilson Names Sunny Sanyal as Kluge's Successor
Devices Radiology Oncology Personnel
 HSMN NewsFeed - 12 Dec 2013
Myriad myRisk Hereditary Cancer(TM) Test Significantly Improves Detection of Women at Risk for Hereditary Cancer by 51 Percent
Diagnostics Oncology
 HSMN NewsFeed - 27 Nov 2013
Study Suggests Non-Invasive Stereotactic Ablative Body Radiotherapy May Be Suitable Alternative to Surgery for Early-Stage Lung Cancer Patients
Devices Oncology
 HSMN NewsFeed - 27 Nov 2013
Over 110 Attend First Varian Edge(TM) Radiosurgery Symposium to Discuss Advances in Stereotactic Radiosurgery and Stereotactic Ablative Radiotherapy
Devices Oncology
 HSMN NewsFeed - 25 Nov 2013
Cyclacel Announces Data Safety Monitoring Board Recommendation to Continue the SEAMLESS Phase 3 Trial of Sapacitabine in AML
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Nov 2013
3-V Biosciences Names Dr. William McCulloch Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Oct 2013
Stem Cell Therapeutics Receives U.S. Orphan Drug Designation for the Use of Tigecycline to Treat Acute Myeloid Leukemia
Regenerative Medicine Oncology FDA
 HSMN NewsFeed - 16 Oct 2013
Seragon Pharmaceuticals Raises $30M in Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 3 Oct 2013
Pfizer Inc. Announces FDA Approval of DUAVEE(TM) (conjugated estrogens/ bazedoxifene) for the Treatment of Moderate-to-Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause and the Prevention of Postmenopausal Osteoporosis [1]
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Sep 2013
Varian Medical Systems Announces First Orders of the Edge(TM) Radiosurgery Suite -- A Comprehensive Solution for Non-Invasive Surgical Procedures
Devices Oncology Product Launch
 HSMN NewsFeed - 26 Aug 2013
GeneDx Introduces Advanced Genetic Test Panels for Inherited Cancer Including Breast and Colon Cancer
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 13 Aug 2013
Elekta: Lawsuit with Varian Medical Systems resolved
Devices Oncology Litigation
 HSMN NewsFeed - 30 Jul 2013
Sialix Raises $1.0 Million in Second Round of Series B Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 24 Jul 2013
Verastem Receives Orphan Drug Designation from the U.S. FDA for Defactinib in Mesothelioma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Jul 2013
Seattle's Swedish Cancer Institute Acquires Four Elekta Versa HD Radiation Therapy Systems
Devices Oncology
 HSMN NewsFeed - 13 Jun 2013
Supreme Court Upholds Myriad's cDNA Patent Claims
Diagnostics Oncology Litigation
 HSMN NewsFeed - 13 Jun 2013
GeneDx to Launch Comprehensive Breast Cancer Genetic Test
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 12 Jun 2013
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 May 2013
NW Bio Initiates Phase III DCVax(R)-L Brain Cancer Trial In Europe: King's College Hospital In The UK Is First Site To Open
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 May 2013
FANG(TM) Personalized Tumor Vaccine Stimulates Immune Response and More than Doubles Time to Recurrence in Patients with Advanced Stage Ovarian Cancer
Biopharmaceuticals Personalized Medicine Oncology
 HSMN NewsFeed - 15 May 2013
RaySearch Laboratories: RaySearch receives 510(k) clearance for RayStation(R) 3.5
Devices Oncology FDA
 HSMN NewsFeed - 23 Apr 2013
VentiRx Pharmaceuticals Appoints James Kyle Bryan, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2013
Prostate Cancer Patient Receives First Treatment Using Latest Version of Vitesse Real-Time Brachytherapy Planning System from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 11 Apr 2013
Varian Medical Systems to Exhibit TrueBeam(TM) System for Image-Guided Radiotherapy and Radiosurgery at ITEM Exhibition in Yokohama, Japan
Devices Oncology
 HSMN NewsFeed - 10 Apr 2013
Lilly Debuts Early Oncology Pipeline Data At AACR Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Mar 2013
Varian Medical Systems Appoints Deepak "Dee" Khuntia M.D. Vice President of Medical Affairs
Devices Oncology Personnel
 HSMN NewsFeed - 15 Mar 2013
RaySearch Laboratories: RayStation(R) 3.5 Released
Devices Oncology Product Launch
 HSMN NewsFeed - 13 Mar 2013
Vermillion Appoints Thomas McLain as President and Chief Executive Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 11 Mar 2013
Precision Therapeutics Announces Topline Prospective Clinical Data Demonstrating Significant Improvement in Overall Survival and Progression Free Survival in Recurrent Ovarian Cancer using Personalized Chemotherapy Diagnostic ChemoFx(R)
Diagnostics Oncology Personalized Medicine
 HSMN NewsFeed - 6 Mar 2013
Elekta: Kuopio University Hospital First in Finland with Elekta’s New Beam Shaping Innovation for Radiotherapy of Cancer Patients
Devices Oncology
 HSMN NewsFeed - 5 Mar 2013
Varian Medical Systems to Showcase Fast, Reliable, Wireless X-ray Image Detectors at the ECR Annual Meeting in Vienna Next Week
Devices Radiology
 HSMN NewsFeed - 4 Mar 2013
The Radiosurgery Society(TM) Completes the 2013 Scientific Meeting Focused on Bridging the Gap: Working Together
Devices Oncology
 HSMN NewsFeed - 14 Feb 2013
Verastem Files for Orphan Disease Status for VS-6063 in Mesothelioma
Biopharmaceuticals Oncology Regulatory FDA
 HSMN NewsFeed - 7 Feb 2013
Amgen Outlines Long-Term Strategy
Biopharmaceuticals
 HSMN NewsFeed - 24 Jan 2013
Varian Medical Systems Receives FDA 510(k) Clearance for Vitesse(TM) Brachytherapy Treatment Planning Software
Devices Oncology FDA
 HSMN NewsFeed - 24 Jan 2013
Varian Medical Systems Receives FDA 510(k) Clearance for the Edge(TM) Radiosurgery Suite for Non-Invasive Surgical Procedures
Devices Oncology FDA
 HSMN NewsFeed - 21 Jan 2013
Mallinckrodt Announces Approval of New Gablofen(R) Prefilled Syringe
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 3 Jan 2013
Gradalis, Inc. Closes $24 Million in Series B Financing to Advance Late-Stage Trials of FANG(TM) Personalized Cancer Vaccine
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Jan 2013
RaySearch Laboratories: RaySearch and Siemens dissolve partnership
Devices Oncology Licensing
 HSMN NewsFeed - 18 Dec 2012
GRUPO COI First In South America to Order a TrueBeam(TM) System for Treating Cancer with Advanced Image-Guided Radiotherapy and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 5 Dec 2012
Timothy E. Guertin Selected to Join Board of Directors
Devices Wound Care Oncology Personnel
 HSMN NewsFeed - 29 Nov 2012
Northern Centre for Cancer Care Acquires Two TrueBeam(TM) Devices from Varian Medical Systems to Deliver Advanced Radiosurgery Treatments
Devices Oncology
 HSMN NewsFeed - 27 Nov 2012
Vermillion Appoints Bruce A. Huebner as Interim Chief Executive Officer
Diagnostics Oncology Personnel
 HSMN NewsFeed - 20 Nov 2012
Varian Medical Systems to Exhibit New Wireless Flat Panel Detector, Image Processing Software and X-Ray Tubes for Digital Radiography at RSNA
Devices Radiology Oncology
 HSMN NewsFeed - 20 Nov 2012
Varian Medical Systems to Showcase Advanced Technologies for Treating Cancer with Image-Guided Radiotherapy and Radiosurgery at JASTRO Meeting in Tokyo, Japan
Devices Oncology
 HSMN NewsFeed - 12 Nov 2012
Clovis Oncology Announces Negative Outcome of CO-101 in Pivotal LEAP Pancreatic Cancer Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Nov 2012
Novel Cancer Immune Therapy Developer Oncos Therapeutics Appoints Experienced Industry Leader Frans Wuite as President and CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 31 Oct 2012
Varian Medical Systems Highlights a Comprehensive Product Portfolio for the Non-Invasive Treatment of Lung Cancer
Devices Oncology
 HSMN NewsFeed - 30 Oct 2012
Sequana Medical Receives CE-Mark Approval for the use of its alfapump(R) System in Cancer Patients With Malignant ascites
Devices Oncology Regulatory
 HSMN NewsFeed - 28 Oct 2012
Varian Medical Systems Unveils EDGE(TM) Radiosurgery Suite -- A Comprehensive Solution for Non-Invasive Surgical Procedures
Devices Oncology
 HSMN NewsFeed - 25 Oct 2012
Varian Medical Systems Signs Purchase Agreement with Advanced Particle Therapy LLC to Supply Technology for the Georgia Proton Treatment Center to be Operated by Emory Healthcare
Devices Oncology
 HSMN NewsFeed - 22 Oct 2012
Varian Medical Systems Expands Market Leadership Position at 2012 ASTRO Meeting in Boston
Devices Oncology
 HSMN NewsFeed - 15 Oct 2012
Cheng Ching General Hospital Delivers First TrueBeam STx Radiosurgery Treatments in Taiwan
Devices Oncology
 HSMN NewsFeed - 10 Oct 2012
Varian's 'GPS for the Body' Real-Time Tracking System Used for Prostate Patients at Leading U.K. Radiotherapy Clinic
Devices Oncology
 HSMN NewsFeed - 4 Oct 2012
Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 27 Sep 2012
Leading Cancer Center Uses High Intensity Mode on Varian TrueBeam Device to Deliver Precise Brain Radiosurgery
Devices Oncology
 HSMN NewsFeed - 11 Sep 2012
Varian Medical Systems Receives SFDA Clearance to Market the UNIQUE(TM) Radiotherapy System in China
Devices Oncology Regulatory
 HSMN NewsFeed - 6 Sep 2012
UK Hospitals Commence Advanced Stereotactic Lung Cancer Treatments Using RapidArc Radiosurgery
Devices Oncology
 HSMN NewsFeed - 4 Sep 2012
Institut Curie Acquires Four Advanced Radiotherapy Treatment Systems Including Three Varian TrueBeam Devices
Devices Oncology
 HSMN NewsFeed - 29 Aug 2012
Varian Medical Systems Files a Lawsuit in the United States against Elekta
Devices Oncology Litigation
 HSMN NewsFeed - 23 Aug 2012
Varian Medical Systems Establishes Subsidiary in South Korea
Devices Oncology
 HSMN NewsFeed - 15 Aug 2012
Varian Medical Systems to Support an NCI-Sponsored Phase III Study Comparing Radiosurgery with Surgery for the Treatment of Early-Stage High-Risk, Operable Non-Small Cell Lung Cancer
Devices Oncology Surgery
 HSMN NewsFeed - 13 Aug 2012
Erich R. Reinhardt Appointed to Board of Directors of Varian Medical Systems
Devices Oncology Personnel
 HSMN NewsFeed - 13 Aug 2012
Varian Medical Systems' CEO Timothy E. Guertin Announces Plans to Retire; Board of Directors Names Dow R. Wilson as Successor
Devices Oncology Personnel
 HSMN NewsFeed - 25 Jul 2012
EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Jul 2012
Largest Public Hospital in Sydney Delivers First Treatment in Australia Using Advanced TrueBeam Radiotherapy and Radiosurgery Device
Devices Oncology
 HSMN NewsFeed - 4 Jun 2012
Afatinib* delivers unprecedented first line efficacy in patients with EGFR mutation positive lung cancer in registration trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 May 2012
Varian Medical Systems Introduces Radiotherapy Treatment Planning Courses at Leading Russian Cancer Center
Devices Oncology
 HSMN NewsFeed - 30 May 2012
Varian Medical Systems to Showcase Oncology Practice Management Products at the 2012 Annual Meeting of the American Society of Clinical Oncology
Devices Oncology
 HSMN NewsFeed - 17 May 2012
Northwest Bio Provides Update On DCVax(R)-L Brain Cancer Trial
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 May 2012
Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer
Devices Oncology
 HSMN NewsFeed - 16 May 2012
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 May 2012
Varian Medical Systems Redesigns its ProBeam(TM) Proton Therapy User Interface
Devices Oncology
 HSMN NewsFeed - 8 May 2012
Varian Medical Systems Spotlights Advanced Disease Specific Options at ESTRO 2012 in Barcelona
Devices Oncology
 HSMN NewsFeed - 1 May 2012
Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
Devices Oncology
 HSMN NewsFeed - 26 Apr 2012
Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 19 Apr 2012
John Muir Heath’s Medical Centers Recognized for Excellence in Radiation Oncology
Devices Oncology
 HSMN NewsFeed - 12 Apr 2012
New Radiotherapy System Provides More Effective, Safer Cancer Treatment at DMC Huron Valley-Sinai Hospital
Devices Oncology
 HSMN NewsFeed - 12 Apr 2012
Varian Medical Systems Holds Workshop in Advanced Radiotherapy Techniques for African Clinicians
Devices Oncology
 HSMN NewsFeed - 11 Apr 2012
Varian Medical Systems to Showcase TrueBeam(TM) STx with RapidArc(R) Radiosurgery - Technology for Fast, Precise Stereotactic Radiosurgery - at AANS Meeting
Devices Neurosurgery Oncology
 HSMN NewsFeed - 2 Apr 2012
Varian Medical Systems Establishes Office in Hungary to Support Local Radiotherapy Departments
Devices Oncology
 HSMN NewsFeed - 21 Mar 2012
Varian Medical Systems to Exhibit Full Spectrum of Hardware and Software Products for Treating Cancer with Radiotherapy at ChinaMed Exhibition in Beijing
Devices Oncology
 HSMN NewsFeed - 8 Mar 2012
The Radiosurgery Society(TM) Completes its First Scientific Meeting as an Independent Society
Devices Oncology
 HSMN NewsFeed - 6 Mar 2012
Aragon Pharmaceuticals Secures $42 Million in Series C Financing to Advance Pipeline of Therapies Targeting Hormone-Driven Cancers
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 1 Mar 2012
Study Published in Molecular Therapy Shows that Immune Response to FANG(TM) Personalized Cancer Therapeutic Correlates with Prolonged Survival in Patients with Advanced Stage Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Feb 2012
Varian Medical Systems to Exhibit X-Ray Tubes and Flat Panel Detector Technology Enhancements to Improve Digital Imaging at the ECR Annual Meeting
Devices Radiology Cardiology
 HSMN NewsFeed - 16 Feb 2012
Varian Medical Systems to Equip New Proton Treatment Center in Russia
Devices Oncology
 HSMN NewsFeed - 26 Jan 2012
Varian Medical Systems Books $77 Million Order to Equip Proton Treatment Center in Saudi Arabia
Devices Oncology
 HSMN NewsFeed - 23 Jan 2012
Varian Medical Systems Showcases Advanced Radiotherapy Systems for Treating Cancer at 2012 Arab Health Congress and Exhibition
Devices Oncology
 HSMN NewsFeed - 18 Jan 2012
Brain Cancer Patient Receives First TrueBeam STx Treatment in Asia at BGS Global Hospitals in Bangalore
Devices Oncology
 HSMN NewsFeed - 18 Jan 2012
HCG Ahmedabad Becomes First Hospital in India to Deliver Advanced Radiotherapy Treatments Using TrueBeam
Devices Oncology
 HSMN NewsFeed - 9 Dec 2011
Myriad Genetics Presents BRACAnalysis(R) Cost-Effectiveness Study at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium
Diagnostics Oncology
 HSMN NewsFeed - 6 Dec 2011
Varian Medical Systems Adds High Dose Delivery and Prone Breast Treatment Capabilities to Clinac(R) and Trilogy(R) Cancer Treatment Machines
Devices Oncology
 HSMN NewsFeed - 31 Oct 2011
World-Renowned Cancer Center to Become All-TrueBeam Clinic in Battle Against Cancer
Devices Oncology
 HSMN NewsFeed - 28 Oct 2011
Leading Swedish University Hospital Orders Four TrueBeam Radiotherapy Systems from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 11 Oct 2011
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 11 Oct 2011
Aduro BioTech Announces First Patient Treated in Phase 2 Pancreatic Cancer Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Oct 2011
Galena Biopharma Hires Hana B. Moran as Vice President, Regulatory Affairs and Compliance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Oct 2011
Varian Medical Systems Books $88 Million Order to Equip Proton Treatment Center
Devices Oncology
 HSMN NewsFeed - 27 Sep 2011
Varian Medical Systems to Exhibit Product Enhancements Designed to Make Treatment with Varian Radiotherapy and Radiosurgery Systems Faster, Easier, More Accurate, and Cost Effective
Devices Oncology
 HSMN NewsFeed - 19 Sep 2011
Varian Medical Systems Signs Agreement to Acquire Calypso Medical Technologies; Acquisition Adds Products for Tracking Tumor Motion During Radiosurgery and Radiotherapy
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 12 Sep 2011
InterMune Announces Launch of Esbriet(R) (pirfenidone) in Germany
Biopharmaceuticals
 HSMN NewsFeed - 6 Sep 2011
FDA Clears Next-Generation Biomarker Test to Determine Likelihood of Ovarian Cancer in Women Who Present with Adnexal Mass
Diagnostics Oncology FDA
 HSMN NewsFeed - 6 Sep 2011
DelMar Pharmaceuticals Receives FDA IND Approval to Begin Clinical Trials With A New Brain Cancer Treatment
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Aug 2011
Elekta Deepens Integration of MOSAIQ Oncology Information System with Varian TrueBeam Radiotherapy Delivery System
Devices Oncology
 HSMN NewsFeed - 8 Aug 2011
Researchers Find RapidArc(R) Radiotherapy from Varian Medical Systems Can Quickly and Accurately Deliver Total Marrow Irradiation (TMI) Treatments for Patients with Blood Cancers
Devices Oncology
 HSMN NewsFeed - 3 Aug 2011
Al Kindy Hospital in Morocco Carries Out First RapidArc(R) Radiotherapy Treatments in North Africa
Devices Oncology
 HSMN NewsFeed - 2 Aug 2011
New NCCN Patient Guidelines Help Patients Navigate the Maze of Breast Cancer Treatment Options
Oncology
 HSMN NewsFeed - 1 Aug 2011
First Multi-Site Study Evaluates New Targeted Radiation Approach for Shortened, Safer Prostate Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 25 Jul 2011
New Cancer Treatment Device Goes Into Service Today
Devices Neurosurgery Oncology
 HSMN NewsFeed - 6 Jul 2011
Coronado Biosciences Closes $25.8M in Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Jun 2011
Endocyte Names Binh Nguyen, M.D., Ph.D. as Vice President of Clinical Affairs
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Jun 2011
Spectrum Pharmaceuticals Announces Promotions of Steven M. Fruchtman, MD, to Chief Medical Officer, Head of Medical & Regulatory Affairs, and Nozar Azarnia, PhD, to Head of Biostatistics and Data Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2011
Northwest Biotherapeutics Announces Change and Expansion of Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 May 2011
Fujirebio Diagnostics, Inc. Receives FDA 510 (k) Clearance for First Biomarker to Monitor Lung Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 25 May 2011
Cancer Research UK Signs Deal With Centella Therapeutics, Inc. to Launch Clinical Development of Radiotherapy-Enhancing Drug
Devices Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 24 May 2011
Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment
Devices Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 19 May 2011
Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 12 May 2011
Varian Medical Systems Makes Equity Investment and Obtains Option to Purchase Augmenix
Devices Oncology
 HSMN NewsFeed - 12 May 2011
Cancer Treatment Experts Detail Promising New Radiosurgical Techniques for Lung and Liver Cancer Patients
Devices Oncology
 HSMN NewsFeed - 11 May 2011
Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Approaches at the American Urological Association Meeting in Washington, D.C.
Devices Oncology Urology
 HSMN NewsFeed - 6 May 2011
Varian Medical Systems Spotlights Fully Integrated Intensity Modulated Proton Therapy at PTCOG 2011 Meeting
Devices Oncology
 HSMN NewsFeed - 6 May 2011
Varian Medical Systems Spotlights Advanced Radiosurgery Systems at ISRS Congress in Paris, May 8-12
Devices Oncology
 HSMN NewsFeed - 14 Apr 2011
New Brachytherapy Applicator for Endometrial Cancer Patients Introduced at ABS 2011 by Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 23 Mar 2011
Access Pharmaceuticals Appoints Industry Executive Anthony Mottola as Vice President of Managed Care and Market Access
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 23 Mar 2011
Asuragen Launches CE Marked IVD AmplideX(TM) Fragile X Test in Europe
Diagnostics Regulatory
 HSMN NewsFeed - 16 Mar 2011
First Varian High Dose Rate Brachytherapy Afterloader Supplied to Leading China Cancer Hospital
Devices Oncology
 HSMN NewsFeed - 14 Mar 2011
Mira Dx(TM) Dismisses Flawed Study as “Puzzling,” and “Comparing Apples and Oranges”
Diagnostics Oncology
 HSMN NewsFeed - 28 Feb 2011
ZELTIQ(TM) Starts 2011 by Strengthening Management Team
Devices Personnel
 HSMN NewsFeed - 24 Feb 2011
Spectrum Pharmaceuticals Appoints Steven M. Fruchtman, MD, an Industry Veteran, as Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Feb 2011
Third Phase III Study of Avastin-Based Regimen Met Primary Endpoint in Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Feb 2011
Cancer Patients in Bangladesh Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 2 Feb 2011
Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Jan 2011
Varian Medical Systems Announces X-Ray Products Contract With Toshiba Medical Systems
Devices Radiology
 HSMN NewsFeed - 26 Jan 2011
Calypso Medical Names Edward Vertatschitsch President and Chief Executive Officer
Devices Oncology Personnel
 HSMN NewsFeed - 26 Jan 2011
APP Pharmaceuticals Announces Agreement with Teva Pharmaceuticals to Manufacture and Market Gemcitabine HCI for Injection
Biopharmaceuticals Licensing Oncology
 HSMN NewsFeed - 25 Jan 2011
Respected Gynecologist, Lipidologist Joins Atherotech Diagnostics Lab Medical Advisory Board
Diagnostics Cardiology Personnel
 HSMN NewsFeed - 12 Jan 2011
Caris Life Sciences Launches Caris Target Now(TM) Ovarian Profile
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 10 Jan 2011
Varian Medical Systems Receives 510(k) Clearance for its Proton Therapy System
Devices Oncology FDA
 HSMN NewsFeed - 10 Jan 2011
Exelixis’ XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Jan 2011
Melanoma, Ovarian, and Prostate Cancer Treatment Guidelines for Patients Available from NCCN
Oncology
 HSMN NewsFeed - 20 Dec 2010
Myriad Genetics Launches PANEXIA, New Predictive Test for Hereditary Pancreatic and Related Cancers
Diagnostics Oncology
 HSMN NewsFeed - 16 Dec 2010
Calypso Medical and Elekta Corporation Enter into Master Development Agreement for Radiation Therapy Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 13 Dec 2010
Lilly Suspends Phase III Trial in Metastatic Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Dec 2010
Bavarian Nordic Receives Special Protocol Assessment Agreement From the FDA for Phase 3 Trial of PROSTVAC(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 30 Nov 2010
Seattle Genetics Announces Additions to Commercial Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Nov 2010
Saudi Arabia's King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy
Devices Oncology
 HSMN NewsFeed - 2 Nov 2010
Varian Medical Systems to Supply Four Advanced Radiotherapy Treatment Machines to Global Hospitals in India
Devices Oncology
 HSMN NewsFeed - 1 Nov 2010
Calypso Medical Introduces Dynamic Edge(TM) Gating Technology at ASTRO
Devices Oncology
 HSMN NewsFeed - 1 Nov 2010
Doctors in the US and Europe Using TrueBeam System from Varian Medical Systems to Treat Cancers of the Lung, Liver, Pancreas, Head and Neck, Brain, and Spine
Devices Oncology
 HSMN NewsFeed - 29 Oct 2010
CURE Foundation Selects Varian Medical Systems to Supply Radiotherapy Technology for Five New Cancer Centers
Devices Oncology
 HSMN NewsFeed - 27 Oct 2010
Calypso Medical Initiates First Clinical Study Using Real-Time Tracking During Lung Cancer Radiotherapy
Devices Oncology
 HSMN NewsFeed - 26 Oct 2010
Myriad and Abbott Enter Into Cooperative Agreement
Diagnostics Oncology
 HSMN NewsFeed - 11 Oct 2010
Chongqing Cancer Hospital Becomes First Hospital in Southwest China to Offer Cancer Patients Fast, Precise Treatment Using RapidArc(R) Radiotherapy from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 7 Oct 2010
Calypso Medical Receives FDA 510(k) Clearance for Dynamic Edge Gating Technology
Devices Oncology FDA
 HSMN NewsFeed - 5 Oct 2010
Varian Medical Systems and Imris to Co-Develop Revolutionary New MR-Guided Radiation Therapy System
Devices Radiology Oncology
 HSMN NewsFeed - 14 Sep 2010
In the Fast Lane: Shorter Treatment Times for Cancer Patients with Increased Speed, Power and Precision of Radiation Therapy
Devices Oncology
 HSMN NewsFeed - 14 Sep 2010
Clinical Experts Detail How They Use Varian's TrueBeam Technology to Improve the Precision and Speed of Cancer Treatments
Devices Oncology
 HSMN NewsFeed - 10 Sep 2010
Varian Medical Systems Spotlights TrueBeam Treatment System for First Time in Europe at ESTRO 2010, September 12-16, Barcelona
Devices Oncology
 HSMN NewsFeed - 8 Sep 2010
Complex Lung Cancer Treatments Delivered Successfully at Leading Varian-Equipped Proton Therapy Center
Devices Oncology
 HSMN NewsFeed - 7 Sep 2010
Alethia Biotherapeutics Secures C$9.6 Million in Series A Financing to Fund Its Therapeutic Monoclonal Antibody Product Pipeline
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 31 Aug 2010
Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 18 Aug 2010
ImmunoGen, Inc. Announces Orphan Drug Designation Granted to Lorvotuzumab Mertansine for Treatment of Small-Cell Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Jul 2010
Vermillion Announces Relocation of Corporate Offices to Austin, Texas
Diagnostics
 HSMN NewsFeed - 15 Jul 2010
Cancer Patients in Scotland Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 25 Jun 2010
Helicos BioSciences Announces Launch of Diagnostics Business
Diagnostics
 HSMN NewsFeed - 21 Jun 2010
Exelixis Regains Full Rights to Develop and Commercialize XL184
Biopharmaceuticals
 HSMN NewsFeed - 14 Jun 2010
Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Jun 2010
Abbott Receives FDA Clearance for New Ovarian Cancer Test
Diagnostics Oncology FDA
 HSMN NewsFeed - 3 Jun 2010
The ARIA(R) Oncology Information System from Varian Medical Systems Now Certified by Surescripts(R) for E-Prescribing
Devices Oncology
 HSMN NewsFeed - 1 Jun 2010
Prostate Cancer Patient First in Spain to Receive Fast and Precise RapidArc(R) Radiotherapy Treatment from Varian
Devices Oncology
 HSMN NewsFeed - 27 May 2010
Calypso Medical's Real-Time Tumor Tracking Technology Improving Prostate Cancer Care
Devices Oncology
 HSMN NewsFeed - 12 May 2010
Aeterna Zentaris: FDA Approves Investigational New Drug (IND) Application for Doxorubicin Targeted Conjugate Compound, AEZS-108, in Bladder Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 May 2010
U.S. FDA Approves Natazia(TM), a New Oral Contraceptive for the Prevention of Pregnancy
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 May 2010
Varian Medical Systems Equips Three Leading Cancer Centers in Istanbul with Advanced Radiotherapy Technology
Devices Oncology
 HSMN NewsFeed - 29 Apr 2010
Bavarian Nordic Receives FDA Fast Track Designation for PROSTVAC(TM)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Apr 2010
Manhattan Scientifics' Technology Able to Detect Breast Cancer Three Years Earlier Than Mammogram
Devices Oncology
 HSMN NewsFeed - 16 Apr 2010
University Hospital Zurich First in the World to Treat Cancer Patients with New TrueBeam(TM) System from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 14 Apr 2010
Varian Medical Systems Introduces a Trilogy(R) Accelerator With Gated RapidArc(R) and Advanced Motion Management
Devices Oncology
 HSMN NewsFeed - 14 Apr 2010
Varian Medical Systems Introduces Revolutionary New TrueBeam(TM) System for High-Precision Image-Guided Radiotherapy and Radiosurgery
Devices Oncology
 HSMN NewsFeed - 17 Mar 2010
First Installment of Calypso System in the United Kingdom at the Royal Marsden Hospital
Devices Oncology
 HSMN NewsFeed - 17 Mar 2010
Varian Medical Systems to Showcase Image-Guided Radiotherapy, Radiosurgery, and X-ray Imaging Technologies at Major Medical Meetings in Asia During March, 2010
Devices Oncology
 HSMN NewsFeed - 17 Mar 2010
New Data Indicate Effectiveness of Clarient's Ovotax(TM) Test for Ovarian Cancer
Diagnostics Personalized Medicine Oncology
 HSMN NewsFeed - 11 Mar 2010
Leading Varian-Equipped Proton Therapy Center Treats 100th Patient
Devices Oncology
 HSMN NewsFeed - 9 Mar 2010
Varian Medical Systems Names Dr. John Adler as Chief of New Clinical Applications
Devices Oncology Neurosurgery Personnel
 HSMN NewsFeed - 3 Mar 2010
Researchers Pave Way for Tracking of Prostate Motion With a Single kV Imager During Arc Radiotherapy
Devices Oncology
 HSMN NewsFeed - 25 Feb 2010
Manhattan Scientifics Acquires Exclusive Rights to Nanomedicine Technology for Early Cancer Detection and Treatment
Biopharmaceuticals Diagnostics Oncology Acquisitions
 HSMN NewsFeed - 25 Feb 2010
Genentech Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Feb 2010
Urology Study Shows Reduced Side Effects from Radiation for Prostate Cancer with Calypso Medical's Tumor Tracking Technology
Devices Oncology Urology
 HSMN NewsFeed - 16 Feb 2010
EntreMed Receives Orphan Drug Designation for ENMD-2076 in Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Feb 2010
Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval
Diagnostics Oncology FDA
 HSMN NewsFeed - 28 Jan 2010
Merck Receives European Approval for ELONVA(R) (corifollitropin alfa injection), a New Fertility Treatment
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 26 Jan 2010
Two Combination Treatment Regimens Added to Updated NCCN Guidelines for Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Jan 2010
Cancer Patients Gain Greater Access to Intensity Modulated Proton Therapy Treatments at Leading German Clinic
Devices Oncology
 HSMN NewsFeed - 14 Jan 2010
Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test
Diagnostics Regulatory Oncology
 HSMN NewsFeed - 6 Jan 2010
MabCure Launches Clinical Trial to Diagnose Ovarian Cancer
Diagnostics Oncology
 HSMN NewsFeed - 22 Dec 2009
Hope International Centro de Radioterapia of Guatemala Becomes First in Latin America to Treat Cancer Using RapidArc(R) Radiotherapy Technology From Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 18 Dec 2009
Ruediger Naumann-Etienne Appointed to IRIDEX Board of Directors
Devices Personnel
 HSMN NewsFeed - 18 Dec 2009
Aeterna Zentaris Announces Termination of Agreement with sanofi-aventis U.S. for the Development, Commercialization and Licensing of Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Urology
 HSMN NewsFeed - 15 Dec 2009
Access Pharmaceuticals Appoints Sales and Marketing Executive
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Dec 2009
Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments
Devices Oncology
 HSMN NewsFeed - 2 Dec 2009
ImmunoCellular Therapeutics Enters into Option Agreement with The University of Texas M. D. Anderson Cancer Center for a Novel Cancer Stem Cell Therapy
Regenerative Medicine Oncology
 HSMN NewsFeed - 1 Dec 2009
Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center
Devices Oncology
 HSMN NewsFeed - 30 Nov 2009
Physicists and Clinicians at Leading Dutch Cancer Center Report Advances in Stereotactic Lung Tumor Treatments Using RapidArc Radiotherapy from Varian
Devices Oncology
 HSMN NewsFeed - 27 Nov 2009
Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago
Devices Radiology Oncology
 HSMN NewsFeed - 13 Nov 2009
Advances in Radiation Therapy Enable Doctors to Improve the Quality of Treatments for Patients With Head and Neck Cancer
Devices Oncology
 HSMN NewsFeed - 12 Nov 2009
Researchers from UC Irvine Medical Center Find Clinical Advantages to Using RapidArc(R) Radiotherapy for the Stereotactic Treatment of Tumors
Devices Oncology
 HSMN NewsFeed - 10 Nov 2009
Scientific Presentations at 2009 ASTRO Meeting Highlight RapidArc(R) Radiotherapy Technology from Varian Medical Systems
Devices Oncology
 HSMN NewsFeed - 3 Nov 2009
Calypso Medical Partners with Siemens Healthcare in Master Development Agreement to Provide Better Control of Radiation Beam During Cancer Treatment
Devices Oncology
 HSMN NewsFeed - 2 Nov 2009
Calypso Medical Studies Show Potential for Improving Radiotherapy Treatment Accuracy
Devices Oncology
 HSMN NewsFeed - 30 Oct 2009
Varian Medical Systems Selected to Supply Major Project to Bring Advanced Radiotherapy Treatments to North of Portugal
Devices Oncology
 HSMN NewsFeed - 23 Oct 2009
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Oct 2009
Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 16 Oct 2009
Endocyte Officials Announce Close of $26 Million Equity Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Sep 2009
Pioneering Brain Malformation Treatment Performed Using Novalis Tx(TM) Radiosurgery Technology in India
Devices Oncology
Return to NewsFeed  

 Additional items found! 484

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 484 additional stories matching:
Varian
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!